A 2026 target-trial emulation involving 102,361 U.S. veterans with type 2 diabetes found no increased suicidality risk after starting semaglutide vs. sodium-glucose cotransporter-2 inhibitors (SGLT2 inhibitors): suicidal ideation HR 0.99 and suicide attempt/death HR 1.05 after overlap weighting.1 That does not prove semaglutide prevents suicide, but it weakens the broad claim that semaglutide initiation itself …
A Global Burden of Disease analysis estimated that U.S. age-standardized substance-use disorder disability-adjusted life-year rates rose 213.5% from 1990 to 2019, with opioid use disorders producing the steepest increase and the largest state-level burden.1 Research Highlights U.S. cases rose sharply: prevalent substance-use disorder cases increased from 12.6 million in 1990 to 19.5 million in 2019.1 …
An 11-person case series tested delayed-release apple cider vinegar capsules in young adults who had gained weight while taking psychotropic medications, and metabolic markers carried more signal than weight loss. Research Highlights Feasibility was the strongest result: 11 of 12 enrolled participants completed the study, 10 of 11 completers missed 5 or fewer doses, and …
A 2026 BRFSS analysis involving 4,071 U.S. adults who used cannabis and either smoked cigarettes, vaped nicotine, or did both found a strong modality match: people who vaped tobacco were much more likely to vape cannabis than to smoke cannabis.1 For addiction and harm-reduction assessment, the pattern is a route-specific risk signal because smoking, vaping, …
A 2026 emergency department claims analysis estimated 3.87 million United States ED visits in 2021 where take-home naloxone could have been clinically relevant, compared with 226,453 ED-treated opioid-overdose visits in the same database.1 The finding reframes naloxone distribution as an emergency-care workflow for overdose risk, polysubstance exposure, long-term opioid use, and patients who arrive after …
Australian coronial data show that fatal poisonings involving new psychoactive stimulants and hallucinogens were rarely single-drug events. In 70 toxicology-confirmed deaths from 2007 through 2025, 92.9% involved other psychoactive drugs and 75.7% involved multiple stimulants or hallucinogens. Research Highlights Fatal cases were usually polysubstance cases: 65 of 70 deaths (92.9%) had psychoactive drugs beyond the …
A 2026 rat study found that 21 days of late-adolescent tetrahydrocannabinol (THC) exposure produced adult anxiety-like behavior in the elevated plus maze and weaker novel object recognition than vehicle exposure. The controlled animal result gives a biologically anchored model for why repeated high-THC exposure during development remains a real concern.1 Research Highlights Late-adolescent THC exposure …